224 related articles for article (PubMed ID: 9020380)
1. Inhibition of MHC class I antigen presentation by viral proteins.
Früh K; Ahn K; Peterson PA
J Mol Med (Berl); 1997 Jan; 75(1):18-27. PubMed ID: 9020380
[TBL] [Abstract][Full Text] [Related]
2. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway.
Früh K; Gruhler A; Krishna RM; Schoenhals GJ
Immunol Rev; 1999 Apr; 168():157-66. PubMed ID: 10399072
[TBL] [Abstract][Full Text] [Related]
3. Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways.
Lybarger L; Wang X; Harris M; Hansen TH
Curr Opin Immunol; 2005 Feb; 17(1):71-8. PubMed ID: 15653314
[TBL] [Abstract][Full Text] [Related]
4. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells.
Hengel H; Esslinger C; Pool J; Goulmy E; Koszinowski UH
J Gen Virol; 1995 Dec; 76 ( Pt 12)():2987-97. PubMed ID: 8847504
[TBL] [Abstract][Full Text] [Related]
5. Involvement of autophagy in MHC class I antigen presentation.
Øynebråten I
Scand J Immunol; 2020 Nov; 92(5):e12978. PubMed ID: 32969499
[TBL] [Abstract][Full Text] [Related]
6. Cross-presentation: underlying mechanisms and role in immune surveillance.
Rock KL; Shen L
Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
[TBL] [Abstract][Full Text] [Related]
7. Viral immune evasion: Lessons in MHC class I antigen presentation.
van de Weijer ML; Luteijn RD; Wiertz EJ
Semin Immunol; 2015 Mar; 27(2):125-37. PubMed ID: 25887630
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation.
Zhou F
Int Rev Immunol; 2009; 28(5):376-93. PubMed ID: 19811316
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of viral interference with MHC class I antigen processing and presentation.
Yewdell JW; Bennink JR
Annu Rev Cell Dev Biol; 1999; 15():579-606. PubMed ID: 10611973
[TBL] [Abstract][Full Text] [Related]
10. A Flow Cytometry-Based Approach to Unravel Viral Interference with the MHC Class I Antigen Processing and Presentation Pathway.
Praest P; de Buhr H; Wiertz EJHJ
Methods Mol Biol; 2019; 1988():187-198. PubMed ID: 31147941
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus encodes a positive regulator of antigen presentation.
Holtappels R; Gillert-Marien D; Thomas D; Podlech J; Deegen P; Herter S; Oehrlein-Karpi SA; Strand D; Wagner M; Reddehase MJ
J Virol; 2006 Aug; 80(15):7613-24. PubMed ID: 16840340
[TBL] [Abstract][Full Text] [Related]
12. Viral interference with MHC class I antigen presentation pathway: the battle continues.
Ambagala AP; Solheim JC; Srikumaran S
Vet Immunol Immunopathol; 2005 Aug; 107(1-2):1-15. PubMed ID: 15978672
[TBL] [Abstract][Full Text] [Related]
13. Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes.
Reimann J; Böhm W; Schirmbeck R
Biol Chem Hoppe Seyler; 1994 Nov; 375(11):731-6. PubMed ID: 7535058
[TBL] [Abstract][Full Text] [Related]
14. Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis.
Teoh CY; Davies KJ
Arch Biochem Biophys; 2004 Mar; 423(1):88-96. PubMed ID: 14871471
[TBL] [Abstract][Full Text] [Related]
15. Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection.
Manley TJ; Luy L; Jones T; Boeckh M; Mutimer H; Riddell SR
Blood; 2004 Aug; 104(4):1075-82. PubMed ID: 15039282
[TBL] [Abstract][Full Text] [Related]
16. The MHC class I antigen presentation pathway: strategies for viral immune evasion.
Hewitt EW
Immunology; 2003 Oct; 110(2):163-9. PubMed ID: 14511229
[TBL] [Abstract][Full Text] [Related]
17. MHC class I antigen presentation: learning from viral evasion strategies.
Hansen TH; Bouvier M
Nat Rev Immunol; 2009 Jul; 9(7):503-13. PubMed ID: 19498380
[TBL] [Abstract][Full Text] [Related]
18. Role of genetic variations on MHC class I antigen-processing genes in human cancer and viral-mediated diseases.
D'Alicandro V; Romania P; Melaiu O; Fruci D
Mol Immunol; 2019 Sep; 113():11-15. PubMed ID: 29625843
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
[TBL] [Abstract][Full Text] [Related]
20. Principles of MHC class I-mediated antigen presentation and T cell selection.
Ljunggren HG; Thorpe CJ
Histol Histopathol; 1996 Jan; 11(1):267-74. PubMed ID: 8720469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
